Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Magro

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Basic Research in Cardiology|February 1, 2014
Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioningTuncay Yetgin, Michael Magro, Olivier C Manintveld, et al.
Journal of the American Heart Association|August 7, 2017
Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized TrialErnest Spitzer, Martina Frei, Serge Zaugg, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2012
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3)Cihan Simsek, Hector M Garcia-Garcia, Robert-Jan van Geuns, et al.
JACC. Cardiovascular Imaging|September 13, 2014
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patientsMatthijs van Kranenburg, Michael Magro, Holger Thiele, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 4, 2022
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 StudyWillem Lambertus Bor, Anne Johanna Wilhelmina de Veer, Renske H Olie, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 28, 2022
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheromaEnrico Fabris, Balázs Berta, Tobias Hommels, et al.
European Heart Journal|August 4, 2021
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trialElvin Kedhi, Balazs Berta, Tomasz Roleder, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery diseaseSalvatore Brugaletta, Michael Magro, Cihan Simsek, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Basic Research in Cardiology|February 1, 2014
Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioningTuncay Yetgin, Michael Magro, Olivier C Manintveld, et al.
Journal of the American Heart Association|August 7, 2017
Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized TrialErnest Spitzer, Martina Frei, Serge Zaugg, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2012
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3)Cihan Simsek, Hector M Garcia-Garcia, Robert-Jan van Geuns, et al.
JACC. Cardiovascular Imaging|September 13, 2014
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patientsMatthijs van Kranenburg, Michael Magro, Holger Thiele, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 4, 2022
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 StudyWillem Lambertus Bor, Anne Johanna Wilhelmina de Veer, Renske H Olie, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 28, 2022
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheromaEnrico Fabris, Balázs Berta, Tobias Hommels, et al.
European Heart Journal|August 4, 2021
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trialElvin Kedhi, Balazs Berta, Tomasz Roleder, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery diseaseSalvatore Brugaletta, Michael Magro, Cihan Simsek, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Pageof 7